Free Trial

B. Riley Has Lowered Expectations for Hyperfine (NASDAQ:HYPR) Stock Price

Hyperfine logo with Medical background
Remove Ads

Hyperfine (NASDAQ:HYPR - Free Report) had its price target decreased by B. Riley from $1.50 to $1.20 in a research report report published on Thursday,Benzinga reports. B. Riley currently has a buy rating on the stock.

Separately, Wells Fargo & Company increased their price target on shares of Hyperfine from $1.10 to $1.29 and gave the stock an "equal weight" rating in a research note on Tuesday, March 18th.

View Our Latest Stock Analysis on HYPR

Hyperfine Trading Up 1.2 %

NASDAQ HYPR traded up $0.01 on Thursday, hitting $0.83. The company's stock had a trading volume of 1,517,118 shares, compared to its average volume of 358,598. Hyperfine has a 52-week low of $0.76 and a 52-week high of $1.90. The firm has a market cap of $60.55 million, a P/E ratio of -1.46 and a beta of 0.94. The company's 50-day simple moving average is $1.06 and its 200 day simple moving average is $1.00.

Hyperfine (NASDAQ:HYPR - Get Free Report) last released its quarterly earnings results on Monday, March 17th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.02. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. The business had revenue of $2.32 million for the quarter, compared to analysts' expectations of $2.30 million. During the same quarter in the previous year, the business posted ($0.15) earnings per share. On average, research analysts forecast that Hyperfine will post -0.57 EPS for the current fiscal year.

Remove Ads

Institutional Investors Weigh In On Hyperfine

Several hedge funds and other institutional investors have recently added to or reduced their stakes in HYPR. Virtu Financial LLC bought a new stake in shares of Hyperfine during the 4th quarter valued at $25,000. Graypoint LLC bought a new position in shares of Hyperfine in the 4th quarter worth about $44,000. Wealth Enhancement Advisory Services LLC lifted its position in Hyperfine by 64.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company's stock valued at $72,000 after acquiring an additional 32,093 shares during the period. Renaissance Technologies LLC boosted its stake in Hyperfine by 32.9% during the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company's stock worth $187,000 after acquiring an additional 52,500 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Hyperfine by 18.7% in the third quarter. Geode Capital Management LLC now owns 624,520 shares of the company's stock worth $675,000 after purchasing an additional 98,335 shares during the period. 15.03% of the stock is owned by hedge funds and other institutional investors.

Hyperfine Company Profile

(Get Free Report)

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

Recommended Stories

Should You Invest $1,000 in Hyperfine Right Now?

Before you consider Hyperfine, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperfine wasn't on the list.

While Hyperfine currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads